SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-223263
Filing Date
2014-06-03
Accepted
2014-06-03 08:00:53
Documents
13
Period of Report
2014-06-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d737337d8k.htm 8-K 28459
2 EX-99.1 d737337dex991.htm EX-99.1 13738
3 EX-99.2 d737337dex992.htm EX-99.2 48122
4 GRAPHIC g737337ex99_2s10gbgd.jpg GRAPHIC 13456
5 GRAPHIC g737337ex99_2s1gbgd.jpg GRAPHIC 47593
6 GRAPHIC g737337ex99_2s2gbgd.jpg GRAPHIC 10714
7 GRAPHIC g737337ex99_2s3gbgd.jpg GRAPHIC 10714
8 GRAPHIC g737337ex99_2s4gbgd.jpg GRAPHIC 10714
9 GRAPHIC g737337ex99_2s5gbgd.jpg GRAPHIC 10714
10 GRAPHIC g737337ex99_2s6gbgd.jpg GRAPHIC 10714
11 GRAPHIC g737337ex99_2s7gbgd.jpg GRAPHIC 44667
12 GRAPHIC g737337ex99_2s8gbgd.jpg GRAPHIC 10714
13 GRAPHIC g737337ex99_2s9gbgd.jpg GRAPHIC 43472
  Complete submission text file 0001193125-14-223263.txt   387397
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14656 | Film No.: 14885983
SIC: 2836 Biological Products, (No Diagnostic Substances)